<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 268 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page267.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=268">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 268 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 268</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=268"><img src="../thumb/268.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.1.2                                                       2020-04 / 231
       binaem &/ platelet dysfunct., pain at IMI site, superinfects., pseu-  LIZORP, Aurobindo [P/S]   ROCIJECT, Litha [P/S]
       domembr. colit., nephrotoxic., ac.ren.tubul. necros.,hypersens.lead.to   Cefprozil monohydrate equiv.to cefprozil.  Ceftriaxone.
       ac.interstit.nephrit., CNS toxic.incl.convuls.with high dos.& kidn.fail.,   Indications: Mild to mod.sev.U&LRT, otit.med., sinusit., skin & skin   Indications: Bact.septicaem., meningit., intra abdom. infects., skin
       hepatit., cholestat.jaund.    struct., uncompl.UTI caus.by suscept. organ.  & skin struct.infects., bone & joint infects., ren& urin.tract infects.,
       Warnings and special precautions: Penicill. cross-sens., allerg.   (S4) TABS, 41/20.1.1/0586, 0587  resp.tract infects., ear/nose & throat infects., uncomplic. gonorrh. all
       hist., ren.impairm., elderly, ren./ bld.monit.dur.lhigh-dos./prolong.ther.  720375-001: 250 mg, 10, R143,55  caus.by suscept.organ., surg.prophylax.
       Interactions: Kidn.damage risk incr.with gentamic., probenicid   720376-001: 500 mg, 10, R237,46  (S4) INJ. 37/20.1.1/0368, 35/20.1.1/0345, 37/20.1.1/0352
       inhibit.ren.excret.of cephalothin & some other cephalospor., poss.   Dosage: Admin.over 10 days.  703320-001: 0,5 g, 1, R19,88
       enhanc. nephrotox.with cert.loop diurets., poss. antagon. with bac-  Adults & childr.over 12 yrs:  702483-003: 1 g, 1, R13,99
       teriostat.antibact.agents.    URTI: 500 mg every 24 hrs.   702483-004: 1 g, 10, R139,90
       LITHA CEFOXITIN, Litha [P/S]  LRTI: 500 mg 12 hrly.        703319-001: 2 g, 1, R44,46
                                     Sinusit: 250 - 500 mg 12 hrly.
                                                                  Dosage: Admin.IM/IV. IV inj.over 2-4 mins. & IV infus.over at least
       Cefoxitin sod.                Uncomplic.UTI: 500 mg every 24 hrs.  30 mins. Durat.of ther.for min. of 48-72 hrs.aft.pt.afebr./bact.eradicat.
       Indications: Peritonit., intra-abdom., intra-pelv. gynaecolog.infects.,   Adults & childr.over 12 yrs: 1-2 g once dly. Max: 4 g dly. Infts.&
       septicaem., endocardit., UTI incl.uncompl.gonorrh., RTI, bone, joint,   Skin/skin struct.infects: 250 mg 12 hrly.or 500 mg 12-24 hrly.   childr.15 days to 12 yrs: 20-80 mg/ kg bm once dly. Childr.with bm
                                     (S4) SUSP., 43/20.1.1/0535, 0536
       skin & soft tiss.infects., post-op.infect.prophylax.  722507-001: 125 mg/5 ml, 100 ml, R118,18  50 kg or more: Usual adult dos. IV dos.≥50 mg/kg bw infus. over at
       (S4) POWD.FOR INJ. 31/20.1.1/0025  722508-001: 250 mg/5ml, 100 ml, R192,25  least 30 mins. Neonates up to 14 days: 20-50 mg/kg bm once dly.
       894026-004: 1 g, 10, R495,73  Dosage: Admin.over 10 days.  Max: 50 mg/kg dly. Not necess.to different. betw.prem. & term infts.
       Dosage: Admin.IV/IM. Adults: 1-2 g 8 hrly. Max: 3 g 6 hrly.in sev.  Adults & childr.over 12 yrs:  Bact.meningit: Neonates, infts.& childr: Init. 100 mg /kg (not to
       infects. Childr.2 yrs.& old: 20-40  mg/kg 6-8 hrly. Max.tot.dly.dos.in   URTI: 500 mg every 24 hrs.  exceed 4 g) once dly., adapt dos. accord.once organ.& sens.deter-
       sev.infects: 200 mg/kg but not exceed.12 g/day.            min. Adults: 4 g once dly.
       Uncompl.gonorrh: Recomm.sngl.dos: 2 g IM with 1 g oral   LRTI: 500 mg 12 hrly.  Gonorrh: 125 mg IM as sngl.dos.
                                     Sinusit: 250 - 500 mg 12 hrly.
       probenecid.                                                Periop.-prophylax: Sngl.dos.of 1-2 g 30-90  mins.prior to surg.
       Prophylax: Adults: Init: 2 g IV pre-op. then 2 g IV/IM 6 hrly x2 dos.   Uncomplic.UTI: 500 mg every 24 hrs.  Contraindications: Hypersens., penicill.cross-sens., hyperbilru-
                                     Skin/skin struct.infects: 250 mg 12 hrly.or 500 mg 12-24 hrly.
       Childr. 2 yrs.& over: 30-40 mg/kg dos.giv.at above interv. Prophy-  binaem.neonates esp.prems., mix./concur.admin.with Ca contain.
       lact.dos. should not extend beyond 24 hrs.  Childr.1-12 yrs.:  sols.in newborns,
       Contraindications: Safety in pregn.& lactat.not est., porphyr., not   URTI: 7,5 mg/kg 12 hrly.  Side effects: Diarrh., N&V, stomatit., glossit., Ca salts precipitat.in
       for meningit.or childr.und.2 yrs.  Otit.med.: 15 mg/kg 12 hrly.  gallbladd., incr.liv.enzym., pseudomembr. colit., haematoma/bleed.,
       Side effects: Loc./allerg.reacts., GI disturbs.incl. pseudomembr.co-  Skin/skin struct.infects: 20 mg/kg once dly.  eosinophil., thrombcytopen., leukopen., lymphopen., granulocyto-
                                     Sinusit: 7,5 – 15 mg/kg 12 hrly.
       lit., bld.dyscras., anaphylax., hepatit., cholest.jaund., convuls., CNS   pen., haemolyt.anaem., prolong. prothromb.time, agranulocytos.,
       toxic.esp. with high dos.     Contraindications: Cephalospor./penicill./beta-lactam antibiot.  exanthema, allerg.dermatit., prurit., urticar., oed., erythema multi-
       Special precautions: GI dis./allergy hist., pseudomembr. colit.,   sensitiv., childr.und.1 yr., pregn.& lactat.  forme, Stev.Johns.syndr., tox. epiderm. necrolys., dizz., headache,
       penicill.cross-sens., ren. insuff./ fail., concom. aminoglycosid.& other   Side effects: Freq: Eosinophil., GI disturbs. Less freq: Neutropen.,   oligur., genit. mycos., poss.drug precip.in kidn., anaphylact. reacts.,
       potent. nephrotox.meds.       thrombocytopen., prolong. PT/INR, anaphylax., fev., ser. sickn., pseu-  phlebit., fev., shiver.
       Drug interactions: Incr.serum lev.with probenecid, enhanc.ne-  domembr. colit., cholestat. jaund., skin reacts. incl. Stev.John.syndr./  Warnings and special precautions: Do not admin. with Ca con-
       phrotoxic.with cert.loop diurets., piperacill.& other beta-lactam an-  erythema multiforme, vaginit., superinfect., prurit., urticar. Unknown.   tain.sols.even via diff.infus. lines/ admin.of Ca cont.sols./prod.to
       tibiot. poss.antagonis.       freq: Angioed., dizzin., headache, CNS effs., elev. AST/ ALT/ alkaline   any pt.within 48 hrs.of last ceftriaxone dos., neonates esp. prems.
                                     phosphat./bilirub./bld.urea/ ser. creatin.
       LITHA CEFTRIAXONE, Litha [P/S]  Warnings and special precautions: Cephalospor. accumulat.  at risk of develop.bilirubin encephalopathy, poss. pseudomembr.colit.
       Ceftriaxone sod.equiv.to ceftriaxone  report.in newborn infts., discont. ther.in allerg.react./suspect. pseu-  if diarrh.pres.subseq.to admin., poss.non-suscept.micro-organ.super
       Indications: Suscept.infects.of ren.& urin.tract, peri-op.infect.   domembr. colit., eval.ren.status bef.init.& dur. ther., known/susp.ren.  infects., shadows detect.by gallbladd.sonogram mistak. for gallston.
       prophylax., RTI esp.pneum., bone/ joint/skin/soft tiss.& wounds,   funct.impairm., concom. warfar./ potent diurets., prev.hypersens.re-  usual.follow.high.than recomm. dos., risk fact.assoc.with bil.stas./
       abdom.infects., sepsis., meningit., uncomplic.gonorrh.  acts., superinfect., Susp: contains phenylalanine  bil. sludge seen in pts.develop.pancreatit., cross. placenta & excret.
       (S4) INJ. 34/20.1.1/0043, 0044, 0045  Interactions: Poss.inhibit.of Vit.K synthes., poss. incr.prothromb.  in breast milk, safety in pregn.& lact.not est., sev. ren.fail., safety in
       883357-003: 500 mg, 1 vial, R21,48  times, nephrotoxic.with concom. aminoglycosid.  pregn.& lactat.not est.
       883365-006: 1 g, 1 vial, R15,11                            Interactions: Antagonist.effs.observ.with chloramphenicol
       701204-007: 2 g, 1 vial, R48,04  ORELOX, Sanofi-Aventis [P/S]  SANDOZ CEFPODOXIME, Sandoz [P/S]
       Dosage: Concom.aminoglycos.reqd.in P.aeruginosa infects.  Cefpodoxime proxetil equiv.to cefpodoxime.  Cefpodoxime proxetil equiv.to cefpodoxime.
       Adults & childr.over 12 yrs: 1-2 g dly. Max: 4 g dly. Infts.& childr:   Indications: Suscept.URTI/LRTI.  Indications: Suscept.URTI/LRTI.
       20-80 mg/kg bm dly.depend. on sev.of infect.12-24 hrly. Prem.infts:   (S4) TABS, [P/S] Z/20.1.1/7, A38/20.1.1/0406  (S4) TABS, [P/S] A39/20.1.1/0398.
       Dly dos.not to exceed 50 mg/kg bm.  789224-003: 100 mg, 10, R235,37  710125-001: 100 mg, 10, R99,31
       Gonorrh: 250 mg IM as sngl.dose.  714125-001: 200 mg, 10, R225,50  Dosage: Admin.with meals.
       Bact.meningit: Neonates & childr: Init.100 mg/ kg (not to ex-  Dosage: Admin.with meals  Adults: 100-200 mg 12 hrly.
       ceed 4 g) once dly., reduc.dos. accord. once organism.& sensitiv.est.  Tonsillit./pharyngit./ac.bronchit: 100 mg 12 hrly. Admin.x10 days   (S4) SUSP, [P/S] A39/20.1.1/0397. 40 mg/5 ml.
       Periop.-prophylax: Sngl.dos.of 1-2 g 30-90 mins. prior to surg.  for beta-haemolyt. streptococ. infects.  710126-001: 50 ml, R72,90
       Contraindications: Hypersens., penicill.cross-sens., hyperbilirubi-  Ac sinusit./exacerbat.of chron.bronchit./ pneum: 200 mg 12 hrly.  710126-002: 100 ml, R163,34
       naem.neonates esp.prems., neonates esp.prems.at risk of develop.  (S4) JUNIOR SUSP, [P/S] 27/20.1.1/0564.   Dosage: Admin.with meals.
       bilirubin encephalopathy.     805165-002: 40 mg/5 ml, 50 ml, R133,87  Childr.over 1 yr: 8 mg/kg/day in 2 div. dos. at 12hrly.interv.Guidelines:
       Side effects: Skin/anaphylact.react., GI disturbs., glossit., bld. dys-  805165-010: 40 mg/5 ml, 100 ml, R267,74  10-15 kg: 5 ml 12 hrly. &gt;15 kg: 10 ml 12 hrly.
       cras., headache, dizz., fev., shiver., genit.tract mycos., oligur., loc.  Dosage: Admin.with meals. Aveg.dos: 8 mg/kg/ day admin.in 2 dos.  Contraindications: Cephalospor.hypersens., safety in pregn.& lac-
       reacts. with IV admin., pain at IM site, superinfect., pseudomembr.   Childr.betw. 10 & 15 kg: 5 ml 12 hrly. Greater or equal to 15 kg:   tat.not est., childr.&lt;1 yr., susp. in phenylketonur.
       colit., shadows detect.by gallbladd. sonogram mistak.for gallston.  10 ml 12 hrly.  Side effects: GI disturbs., headache, dizzin., tinnit., paraesthes.,
       usual.follow.high. than recomm.dos.  Contra-indications: Cephalospor./ ß-lact. hypersens., safety in   asthen., hypersens.reacts.incl. anaphylax., haematologic.disords.
       Special precautions: Sev.ren./hepat.dysfunct., pregn.& lactat.,   pregn.& lactat. not est., childr. &lt;1 yr.as insuffic.clinic.data avail.,   Special precautions: Penicill.& ß-lactam cross sensitiv., super
       monit.bld.profile dur.prolong.ther.  Susp also: Phenylketonur.  infect., pseudomembran.colit., ren. impairm., GI dis.hist.esp.ulcerat.
       Drug interactions: Antagonist.effs.with chloramphenic. observ.  Side-effects: Eosinophil., fev., angioed., bronchosp., malaise, ana-  colit./reg.enterit./ antibiot.assoc.colit.
                           2++
       in in-vitro study, should not be admin.with Ca  cont.sols./prod.in   phylact.shock, rash, cutan.erupt., prurit., urticar., purpura, ser.sickn.-  Drug interactions: Antacids & histam.H 2-recept. antagon. decr.
       newborns as risk of precipitat.of ceftriaxone salt.  like reacts., bullous erupt./eryth.multiforme/Stev.-Johns. syndr., GI   absorpt., probenecid reduc.ren. excret.
                                     disturbs.incl.diarrh., hepatit., cholestas., bld.dyscras., headache, dizzy
       LITHA CEFUROXIME, Litha [P/S]  sensat., paraesthes., tinnit., asthen., malaise,  SANDOZ-CEFTRIAXONE 0,5; 1 & 2 g, Sandoz [P/S]
       Cefuroxime as cefuroxime sodium  Special precautions: Penicill.& ß-lactam cross sensitiv., ser.  Ceftriaxone sod.equiv.to ceftriaxone
       Indications: RT, ENT UT, bone & joint, soft tiss,. obstet & gynae in-  hypersens.reacts.somet.fatal, discont.ther.in case of allerg.react.,   Indications: Bact.septicaem., meningit., intra-abdom. /skin & skin
       fects.caus.by suscept.infects, gonorrh. & infect.prophylax.in abdom./  ren.impairm., discont.ther.if pseudomembran.colit.sympt.occur &   struct./bones & joint/ ren.& urin.tract/resp.tract & ENT infects., un-
       card/& pulm.surg.where infect.risk incr.  init.appropr.antibiot.ther., GI dis.hist. esp.ulcerat.colit./reg.enterit./  complic. gonorrh., peri-op.infect.prophylax.
       (S4)POWD.FOR INJ, 30/20.1.1/0483, 0484, 0485.  antibiot.assoc.colit.,  (S4) INJ. 41/20.1.1/0866, 0867, 0868
       894846-002: 250 mg, 10 vials, R174,09  Drug interactions: Antacids & histam.H 2-recept. antagon.reduc.  710966-001: 0,5 g, 1 vial, R42,98
       892416-009: 750 mg, 10 vials, R191,51  bioavail., probenecid reduc.ren. excret.,  710967-001: 1 g, 1 vial, R46,53
       701205-003: 1,5 g, 10 vials, R383,01                       710968-001: 2 g, 5 vial, R88,32
       Dosage: Admin IM/IV or as IV infus.  RANCEPH, Ranbaxy [P/S]  Dosage: Admin.IM/IV. IV infus.to be admin.over at least 30 mins.
       Adults: Dos.range: 1,5-6 g/day. Many infects. respond to 750 mg   Cephalexin monohydrate equiv.to cephalexin.  Durat.of ther.for min.of 48-72 hrs.aft.pt.afebr./eviden.bact.eradicat.
       8 hrly & sev.infects 1,5 g IV 8 hrly. Freq.of IM or IV inj.may be incr.  Indications: Suscept.organ.resp.tract., GU tract, skin & soft tiss.  Adults incl.elderly & childr. over 12 yrs: 1-2 g once dly.may be
       to 6 hrly if necess.          infects., otit.media, dent.infects.  incr.to 4 g dly.
       Infts & childr: 30-100 mg/kg/day in 3-4 div.dos. Dos. for most in-  (S4) CAPS. 30/20.1.1/0334, 0335.  Neonates upto 14 days (not necess.to different. betw.prem.&
       fects: 60 mg/kg/day.          830909-001: 250 mg, 20, R15,40  term infts): 20-50 mg/kg bm once dly. Dly.dos not to exceed 50 mg/
       Gonorrh: 1,5 g as sngl.dos.   837253-004: 500 mg, 20, R30,28  kg. Neonates, infts.& childr.(15 days to 12 yrs): 20-80 mg/kg bm
       Surg.infect.prophylax: Abdom.& gynae ops: 1,5 g IV at   (S4) SUSP, 32/20.1.1/0214, 0215  once dly. Adult dos.applic.to childr.with bm. over 50 kg.
       anaesth.induct., may be supplem.with 2 x 750 mg 8 & 16 hrs.later.   860603-008: 125 mg/5 ml, 100 ml, R29,06  Bact.meningit: Neonates/ infts.& childr: Init. 100 mg/kg (not to
       Card.& pulm.op: 1,5 g IV at anaesth.induct.contin.with 750 mg 8   860611-019: 250 mg/5 ml, 100 ml, R28,83  exceed 4 g) once dly.
       hrly x24-48 hrs.              Dosage: Adults: Dos.range 1-4 g dly.in equal div.dos. Usual dos:   Adults: Recomm.4 g once dly.
       Contraindications: Safety in pregn.& lactat.not est.  250 mg 6 hrly.or 500 mg 12 hrly.Childr. Usual recomm. 25-50 mg/kg   Gonorrh: 250 mg IM as sngl.dose.
       Side effects: Thrombophlebit.aft.IVI, GI disturbs., hypersens.reacts.,   bm/ day in div.dos.6 hrly.  Periop.infect.-prophylax: Sngl.dos.of 1-2 g 30-90  mins.prior to surg.
       anaphylax.& Stev.John., bld. dyscras., loc.reacts.aft.IMI, non-suscept.  Contra indications: Safety in pregn.& lactat.not est.  Contraindications: Penicill.cross-sens., hyperbilirubinaem. neo-
       organ. overgrowth             Side-effects: Hypersens.reacts., anaphylax., GI disturbs., skin rash,   nates esp.prems., concom. Ca contain.sols./prod., safety in pregn.&
       Special precautions: Poss.penicill./cephalospor. cross sens., imp.  super-infect., bld.dyscras., hepatit., cholestat.jaund., CNS toxicity with   lactat. not est.
       ren.funct., poss.pseudomembr. colit., avoid concom.furosemide, con-  high dos.esp.in ren.fail., vulv.irrit., CNS effs., fatig.  Side effects: Fatal reacts.with precipitat.of ceftriaxone salts in lung
       com. aminoglycosid.seems to incr.nephrotox.  Special precautions: Penicill.cross-sens., allerg. hist., imp.ren.  & kidn.of term & prem. neonates, precipitat.of ceftriaxone salts in gall-
       Drug interactions: Furosemide enhanc. nephrotox. potent.  funct., pseudomembran.colit.  bladd., GI disturbs., stomatit., glossit., incr.liv enzym., pseudomembr.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page267.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page263.html">263</a>&nbsp;&nbsp;&nbsp;<a href="page264.html">264</a>&nbsp;&nbsp;&nbsp;<a href="page265.html">265</a>&nbsp;&nbsp;&nbsp;<a href="page266.html">266</a>&nbsp;&nbsp;&nbsp;<a href="page267.html">267</a>&nbsp;&nbsp;&nbsp;<a href="page268.html">268</a>&nbsp;&nbsp;&nbsp;<a href="page269.html">269</a>&nbsp;&nbsp;&nbsp;<a href="page270.html">270</a>&nbsp;&nbsp;&nbsp;<a href="page271.html">271</a>&nbsp;&nbsp;&nbsp;<a href="page272.html">272</a>&nbsp;&nbsp;&nbsp;<a href="page273.html">273</a>
             </td>
             <td width="35%"><a href="page269.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page269.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
